---
title: "HIMS 最後期限提醒：ROSEN，值得信賴的投資者顧問，建議 Hims & Hers Health, Inc.的投資者在 8 月 25 日重要截止日期之前，若損失超過 10 萬美元，請尋求法律顧問"
description: "紐約，紐約——（Newsfile Corp. -2025 年 8 月 10 日）——為什麼：羅森律師事務所，一家全球投資者權益律師事務所，提醒在 2025 年 4 月 29 日至 2025 年 6 月 23 日期間（包括這兩個日期）購買 Hims & Hers Health, Inc.（紐約證券交易所代碼：HIMS）普通股的投資者注意"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/252386570.md"
published_at: "2025-08-10T17:09:44.000Z"
---

# HIMS 最後期限提醒：ROSEN，值得信賴的投資者顧問，建議 Hims & Hers Health, Inc.的投資者在 8 月 25 日重要截止日期之前，若損失超過 10 萬美元，請尋求法律顧問

> 紐約，紐約——（Newsfile Corp. -2025 年 8 月 10 日）——為什麼：羅森律師事務所，一家全球投資者權益律師事務所，提醒在 2025 年 4 月 29 日至 2025 年 6 月 23 日期間（包括這兩個日期）購買 Hims & Hers Health, Inc.（紐約證券交易所代碼：HIMS）普通股的投資者注意

New York, New York-- ( Newsfile Corp. - August 10, 2025 ) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. ( NYSE: HIMS ) between April 29, 2025 and June 23, 2025, both dates inclusive ( the "Class Period" ) , of the ...

### Related Stocks

- [HIMS.US - Hims & Hers Health](https://longbridge.com/zh-HK/quote/HIMS.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| BUZZ-Hims sinks to over-one-year low after Novo Nordisk patent‑infringement lawsuit | Shares of Hims & Hers Healthfell 28.5% to $16.45, marking its lowest point since October 2024, following a patent-infrin | [Link](https://longbridge.com/zh-HK/news/275336227.md) |
| Hims & Hers stock is crashing: will it rebound soon? | Hims & Hers stock has plummeted over 56% since July, dropping its market cap from $14.85 billion to $7.7 billion. The st | [Link](https://longbridge.com/zh-HK/news/272293460.md) |
| Norwegian Cruise Line stock is rising. A big activist reportedly has taken a stake. | Norwegian Cruise Line's stock rose 6% in premarket trading after reports that activist investor Elliott has acquired ove | [Link](https://longbridge.com/zh-HK/news/276111879.md) |
| Compass Pathways Reports Positive Phase 3 Results for Psilocybin in Treatment-Resistant Depression | Compass Pathways plc has reported positive results from its second Phase 3 clinical trial of COMP360, a synthetic psiloc | [Link](https://longbridge.com/zh-HK/news/276117008.md) |
| Beirne Wealth Consulting Services LLC Purchases 23,723 Shares of Pan American Silver Corp. $PAAS | Beirne Wealth Consulting Services LLC increased its stake in Pan American Silver Corp. (NYSE: PAAS) by 83.5% in Q3, acqu | [Link](https://longbridge.com/zh-HK/news/276109304.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。